Our Services
Medical Information
Helpful Resources
Published on: 5/5/2026
Platelet-rich plasma uses your own blood’s concentrated growth factors to accelerate healing of corneal ulcers, offering faster surface closure, reduced pain and infection risk, and the potential to avoid surgery compared to standard drops and ointments. Clinical studies show improved comfort and long-term stability, but protocols vary and specialist oversight is essential.
There are several factors to consider before pursuing PRP for eye surface healing—including preparation methods, candidate suitability, risks and follow-up care. See below for important details that may impact your next steps.
Saving Vision: Using Plasma to Speed Up Eye Surface Healing
Corneal ulcers are open sores on the eye's surface that can cause pain, redness, light sensitivity and vision loss if left untreated. Traditional treatments include antibiotic drops, lubricating ointments and, in severe cases, surgery. In recent years, platelet-rich plasma (PRP) has emerged as an innovative, biologic therapy to accelerate healing and reduce complications. Below, we explore how PRP for corneal ulcers works, the benefits and risks, and what you should consider before pursuing this treatment.
What Is PRP and How Does It Help the Eye?
Platelet-rich plasma is derived from a small sample of your own blood. Through a process of centrifugation, platelets and growth factors are concentrated into a liquid you can apply to the eye surface. Key healing components in PRP include:
• Growth factors (PDGF, TGF-β, EGF) that stimulate cell migration and division
• Cytokines that modulate inflammation
• Fibrinogen for a supportive scaffold on the corneal surface
When applied as eye drops or gels, PRP delivers high concentrations of these factors directly to damaged tissue, jump-starting repair mechanisms.
Why Speeding Up Corneal Healing Matters
Corneal ulcers carry serious risks:
• Scarring, which can permanently impair vision
• Secondary infections leading to deeper eye involvement
• Perforation of the cornea in extreme cases
• Need for corneal transplant if conservative therapy fails
Faster, more effective healing not only preserves vision but may reduce the need for invasive procedures. PRP's targeted, biologic approach offers several advantages:
• Enhanced epithelial (surface) closure
• Reduced inflammation and pain
• Lower risk of infection by restoring the natural barrier
• Potential to avoid surgery or accelerate post-surgical recovery
Clinical Evidence for PRP in Corneal Ulcers
A growing body of peer-reviewed studies supports PRP use in eye surface disorders:
• Accelerated healing: In randomized trials, patients with non-healing epithelial defects treated with autologous PRP achieved complete closure faster than those on standard lubricants.
• Improved comfort: PRP users often report reduced pain and light sensitivity within days of starting therapy.
• Long-term stability: Follow-up studies show lower recurrence rates of ulceration and more stable corneal surfaces.
While research is promising, protocols vary between clinics in terms of platelet concentration, application frequency and treatment duration. Collaboration with an experienced eye specialist is essential for optimal outcomes.
Preparing and Applying PRP for the Eye
Your eye doctor will tailor the regimen based on ulcer size, depth and healing progress.
Benefits of PRP Over Conventional Treatments
Traditional therapies often rely on antibiotics, anti-inflammatories and artificial tears. PRP offers unique advantages:
• Autologous source—no risk of allergic reaction or disease transmission
• Biologic factors that mimic natural healing processes
• Potential to reduce dependency on topical steroids (which can raise eye pressure)
• Enhanced comfort compared with preservative-containing drops
Comparing PRP with Autologous Serum Eye Drops
Autologous serum tears (AST) use blood serum without platelets. While AST can aid healing, PRP delivers higher concentrations of growth factors. Many specialists view PRP as a next-generation advancement over AST for stubborn ulcerations.
Possible Risks and Limitations
PRP is generally safe, but no therapy is without limitations:
• Transient discomfort or mild burning on application
• Risk of contamination if preparation isn't strictly sterile
• Variable efficacy: not all patients respond equally
• Cost and availability: not yet standard in all eye clinics
Discuss potential side effects and expected timelines with your provider.
Who Is a Good Candidate for PRP?
PRP may be appropriate for those with:
• Non-healing or recurrent corneal ulcers despite standard care
• Autoimmune-related epithelial defects (e.g., rheumatoid arthritis)
• Severe dry eye syndromes complicating ulcer healing
• Intolerance to preservatives or medications in conventional drops
Patients with active infections (bacterial, fungal, viral) must complete antimicrobial therapy before PRP, as growth factors could potentially feed pathogens. Full evaluation by an ophthalmologist is critical.
Monitoring Progress and Adjusting Treatment
Regular follow-up visits include:
• Slit-lamp examinations to assess epithelial closure
• Measurement of ulcer size and depth
• Intraocular pressure checks if steroids are used concurrently
• Symptom review: pain, redness, tearing, vision changes
Based on healing rates, your doctor may adjust application frequency, switch to maintenance drops or proceed with surgical interventions if needed.
How to Get Started
If you're experiencing eye symptoms like pain, redness or vision changes, our Medically Approved LLM Symptom Checker can help you understand what might be happening and guide your next steps before your appointment.
Key Takeaways
• PRP for corneal ulcers harnesses your body's own growth factors to accelerate surface healing.
• Clinical studies show faster closure, less pain and reduced complications compared to conventional therapy.
• Proper preparation, sterile technique and specialist oversight are essential to maximize benefits.
• Not all patients respond; discuss risks, costs and alternatives thoroughly with your eye care provider.
Speak to Your Doctor
PRP therapy offers hope for those struggling with slow-healing or recurrent corneal ulcers, but it's not a substitute for professional medical advice. If you experience sudden vision changes, severe pain, eye discharge or trauma, seek immediate care. Always speak to a doctor about anything that could be life-threatening or serious.
(References)
Chen S, Yu S, Shi T, Fang C, Li R. Platelet-Rich Plasma in the Treatment of Ocular Surface Diseases: A Systematic Review and Meta-Analysis. Cornea. 2024 Apr 1;43(4):479-487. doi: 10.1097/ICO.0000000000003460. PMID: 38051759.
Hwang HR, Kim JH, Lee JH. Current Applications of Platelet-Rich Plasma in Ocular Surface Diseases. J Clin Med. 2023 Jan 24;12(3):939. doi: 10.3390/jcm12030939. PMID: 36769588.
Alio Del Barrio JL, Pastor S, Alio JL. Platelet-Rich Plasma for Ocular Surface Diseases: A Narrative Review. Acta Ophthalmol. 2021 May;99(3):e265-e274. doi: 10.1111/aos.14660. PMID: 33140683.
Al-Said B, Kuriakose T. Autologous Serum Eye Drops, Platelet-Rich Plasma, and Other Blood-Derived Products for Ocular Surface Disease. J Ophthalmol. 2021 Dec 28;2021:6451608. doi: 10.1155/2021/6451608. PMID: 35003664.
Akhtar S, Qiao L, Lee Z. Therapeutic Use of Plasma Eye Drops: A Review. J Ocul Pharmacol Ther. 2017 Mar;33(2):65-71. doi: 10.1089/jop.2016.0094. PMID: 27726584.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.